Literature DB >> 24470448

Editorial: interferon-γ: friend or foe in systemic juvenile idiopathic arthritis and adult-onset Still's Disease?

Scott W Canna1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24470448      PMCID： PMC4181835          DOI： 10.1002/art.38362

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  16 in total

1.  Clinical manifestations of Adult-onset Still's disease presenting with erosive arthritis: Association with low levels of ferritin and Interleukin-18.

Authors:  Hisae Ichida; Yasushi Kawaguchi; Tomoko Sugiura; Kae Takagi; Yasuhiro Katsumata; Takahisa Gono; Yuko Ota; Sayuri Kataoka; Hidenaga Kawasumi; Hisashi Yamanaka
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

Review 2.  Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.

Authors:  Gina A Montealegre Sanchez; Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Rheum Dis Clin North Am       Date:  2013-09-21       Impact factor: 2.670

3.  Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

Authors:  Edward M Behrens; Scott W Canna; Katharine Slade; Sheila Rao; Portia A Kreiger; Michele Paessler; Taku Kambayashi; Gary A Koretzky
Journal:  J Clin Invest       Date:  2011-05-16       Impact factor: 14.808

4.  Amplification of the response to Toll-like receptor ligands by prolonged exposure to interleukin-6 in mice: implication for the pathogenesis of macrophage activation syndrome.

Authors:  Raffaele Strippoli; Francesco Carvello; Roberta Scianaro; Loredana De Pasquale; Marina Vivarelli; Stefania Petrini; Luisa Bracci-Laudiero; Fabrizio De Benedetti
Journal:  Arthritis Rheum       Date:  2012-05

5.  Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles.

Authors:  Masaki Shimizu; Yasuo Nakagishi; Akihiro Yachie
Journal:  Cytokine       Date:  2012-12-29       Impact factor: 3.861

6.  Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice.

Authors:  Philippe Krebs; Karine Crozat; Daniel Popkin; Michael B Oldstone; Bruce Beutler
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

7.  Adult-onset Still disease as the cause of fever of unknown origin.

Authors:  José C Crispín; Deborah Martínez-Baños; Jorge Alcocer-Varela
Journal:  Medicine (Baltimore)       Date:  2005-11       Impact factor: 1.889

8.  Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.

Authors:  Scott W Canna; Julia Wrobel; Niansheng Chu; Portia A Kreiger; Michele Paessler; Edward M Behrens
Journal:  Arthritis Rheum       Date:  2013-07

9.  Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses.

Authors:  Hideaki Ohyagi; Nobuyuki Onai; Taku Sato; Satoshi Yotsumoto; Jiajia Liu; Hisaya Akiba; Hideo Yagita; Koji Atarashi; Kenya Honda; Axel Roers; Werner Müller; Kazutaka Kurabayashi; Mayuka Hosoi-Amaike; Naoto Takahashi; Makoto Hirokawa; Kouji Matsushima; Kenichi Sawada; Toshiaki Ohteki
Journal:  Immunity       Date:  2013-09-12       Impact factor: 31.745

10.  Hemophagocytosis causes a consumptive anemia of inflammation.

Authors:  Erin E Zoller; Jennifer E Lykens; Catherine E Terrell; Julio Aliberti; Alexandra H Filipovich; Peter M Henson; Michael B Jordan
Journal:  J Exp Med       Date:  2011-05-30       Impact factor: 14.307
View more
  7 in total

Review 1.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

Review 2.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 3.  Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Fabio Martinon; Alexandre Belot; Thomas Henry; Pascal Sève
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 4.  Treatment of adult-onset Still's disease: a review.

Authors:  Yvan Jamilloux; Mathieu Gerfaud-Valentin; Thomas Henry; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2014-12-22       Impact factor: 2.423

5.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

Review 6.  Interferon target-gene expression and epigenomic signatures in health and disease.

Authors:  Franck J Barrat; Mary K Crow; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606

Review 7.  Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

Authors:  Anneleen Avau; Patrick Matthys
Journal:  Pharmaceuticals (Basel)       Date:  2015-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.